Lyra Therapeutics, Inc. (NASDAQ:LYRA) Sees Large Decrease in Short Interest
MarketBeat
Lyra Therapeutics, Inc. (NASDAQ:LYRA - Get Free Report) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 146,600 shares, a decrease of 94.6% from the April 30th total of 2,700,000 shares. Based on an average daily trading volume, of 63,800 shares, the short-interest ratio is presently 2.3 days. Currently, 13.1% of the shares of the company are short sold.
NASDAQ:LYRA